Search

everythinglearnresearchcommunity

for

Search:↓

Current corticosteroid pulse therapy is not very effective for severe rapidly progressive alopecia areata.

The conclusion is that effective cancer treatment often requires a combination of therapies, but must be carefully managed due to serious side effects and the risk of immunosuppression.

Abrocitinib at 100 mg and 200 mg daily may significantly improve moderate-to-severe atopic dermatitis in patients 12 years and older.

Higher doses of oestradiol implants improve bone density in postmenopausal women.

Low-dose finasteride and dutasteride reduce PSA levels by 27.8% in men with male androgenetic alopecia.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

Small hormonal imbalances can cause significant health problems, so more sensitive testing for hormone-disrupting chemicals is needed.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

High-dose radiation speeds up aging in skin stem cells.

High-dose vitamin D3 does not improve symptoms or quality of life in COVID-19 patients after one year.

The decision tree can predict drug absorption issues with good accuracy but needs more validation and adjustments for other factors.

The guidelines suggest lifestyle changes, diet adjustments, and personalized medication to manage dyslipidemia and reduce heart disease risk.

Type 2 diabetes does not change how metformin works in obese pregnant women, so dosage adjustments are not needed.

A kidney transplant patient on cyclosporin experienced unexpected severe hair loss, which improved with treatment adjustments.

New treatments for skin and hair disorders in women of color address unique biological differences and include specific acne medications, sunscreens, skin lighteners, and hair care adjustments.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Women treated with X-ray for scalp fungus as children had a higher chance of hair loss, especially with higher radiation doses and severe fungus infections.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

Zinc can both inhibit and stimulate mouse hair growth, and might help recover hair after chemotherapy.

Natesto nasal gel improves erectile function and mood in men with low testosterone within 30 days.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

Tofacitinib can help hair grow back in alopecia patients but hair loss might return if the dose is lowered.

People with obstructive sleep apnea are more likely to get herpes zoster, but nightmares don't affect the risk.

The document concludes that H2-antagonists and proton pump inhibitors are highly effective for ulcers, eradicating Helicobacter pylori is important to prevent recurrence, and misoprostol helps with NSAID-related ulcers.

Trilostane effectively and safely treats dogs with pituitary-dependent hyperadrenocorticism, improving symptoms and adrenal gland size.

Chemotherapy often causes hair loss, nail changes, and mouth issues, but these are usually manageable.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.